Sickle cell disease: a comprehensive program of care from birth

Area of Science:

• Pediatrics
• Hematology
• Global Health

Background:

• Sickle cell disease (SCD) burden is rising globally, particularly in Africa, the US, and Europe, due to improved diagnosis.
• Newborn screening for SCD is not universally implemented, delaying early management.
• Point-of-care testing shows promise for SCD diagnosis in low-resource settings.

Purpose of the Study:

• To highlight the increasing global burden of sickle cell disease in children.
• To emphasize the need for early diagnosis, comprehensive care strategies, and improved access to treatment.
• To discuss the challenges and recommendations for managing SCD in diverse healthcare settings.

Main Methods:

• Review of current literature and clinical practices in SCD management.
• Analysis of diagnostic tools, including point-of-care testing.
• Discussion of care network development and preventative programs.

Main Results:

• Early diagnosis and management are critical but hindered by inconsistent newborn screening.
• Point-of-care tests offer good sensitivity and specificity for SCD detection.
• Care networks and comprehensive programs (pneumococcal, malaria, stroke prevention) can improve patient care.

Conclusions:

• Integrated care networks and standardized protocols are essential for effective SCD management.
• Access to treatments like hydroxyurea needs expansion, especially in African nations.
• Patient and parent education is a key component of comprehensive SCD care.